Navigation Links
FDNY Makes Largest First Responder Purchase of Masimo Rad-57 Pulse CO-Oximeters to Improve Survival of Firefighters and Victims of Carbon Monoxide Poisoning
Date:9/8/2009

IRVINE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that the Fire Department of New York City (FDNY) has purchased 86 Masimo Rad-57 Pulse CO-Oximeters as part of their strategic initiative to "improve the survivability of firefighters and victims suffering from carbon monoxide (CO) toxicity." The purchase is the single largest first responder deployment of Rad-57s, making FDNY the largest department to implement a department-wide program for noninvasive carbon monoxide monitoring in the U.S.

The Masimo Rad-57 Pulse CO-Oximeter enables EMS and fire department first responders to quickly, accurately, and noninvasively detect carbon monoxide poisoning on the scene. FDNY will put its 86 new Rad-57s to work throughout the 5 boroughs of New York City on all 35 of its HazTac and rescue ambulances, Supervisor units, and Major Emergency Response Vehicles -- allowing for prompt and possibly life-saving treatment for both victims and firefighters alike.

According to John Peruggia, Chief of EMS for the Fire Department City of New York, the Masimo Rad-57 Pulse CO-Oximeter has become a key component in FDNY fire and emergency medical response operations "because it allows our EMTs and Paramedics to accurately evaluate a patient's blood chemistry, determine toxicity levels, and commence initial treatment of patients found to be poisoned by CO -- all within seconds. The Rad-57 has also become an integral part of firefighter rehab, with all fire personnel being evaluated for CO after operating at large fire incidents, to insure responder health and safety. Expanding our utilization of the Rad-57 with this purchase is a natural progression of the success we have achieved, both in terms of lives saved and hazards averted."

Masimo Founder and CEO, Joe E. Kiani, stated, "We commend FDNY for their leadership, dedication, and vigilance in the battle against the unsuspected, deadly hazards of carbon monoxide poisoning. We are particularly proud that they have chosen the Rad-57 to help ensure the public health and safety of all New York City residents, visitors, and first responders."

About FDNY

The Fire Department City of New York (FDNY) is the largest combined Fire and EMS provider in the United States. With more than 11,000 firefighters and 3,000 EMTs and paramedics, FDNY provides the fire protection and inspection, emergency medical, technical rescue, and biological, chemical and radioactive hazard first response services for more than 8 million citizens in an area of more than 320 square miles. Annually, FDNY responds to over 990,000 fire calls, more than 1.3 million EMS calls.

About Masimo

Masimo (Nasdaq: MASI) develops innovative monitoring technologies that significantly improve patient care -- helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low-Perfusion pulse oximetry, known as Masimo SET((R)), which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET((R)) Pulse CO-Oximetry(TM), a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO((R))), methemoglobin (SpMet((R))), and PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at www.masimo.com.

Forward Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our belief that Masimo Rad-57 will provide sufficient sensitivity and specificity to detect elevated levels of carboxyhemoglobin and potentially life-threatening carbon monoxide poisoning within seconds for all patients and will provide an effective early warning system to enable timely rescue, as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

    Media Contacts:
    Dana Banks
    Masimo Corporation
    +1 (949) 297-7348

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Radical-7, Rad-87, Rad-57, Rad-9, Rad-8, Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.


'/>"/>
SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Join The Wound, Ostomy & Continence Nurses Society As It Makes History
2. iCRco Makes Inroads in Maritime Healthcare and Completes the First Two Installs on World Renowned Cruise Lines
3. R&B / Pop Vocal Quartet All-4-One Makes 7-Year Comeback
4. Chronic Media Multi-Tasking Makes It Harder to Focus
5. Cornell makes cancer vaccine for clinical use
6. American Home Companions Makes Inc. 5000 List Again
7. CordLife Makes Headway into China
8. NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines
9. HearUSA Makes Hearing Aids and Care Available to AARP Members
10. Unified360 Makes Positive Impact to Baylor Surgical Center Operations.
11. Reprints Desk Makes Pharmaceutical ePrint Procurement Service Available Through FIZ AutoDoc Document Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: